India in Vitro Diagnostics Industry Report
Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Clinical Chemistry, Immunochemistry, Infectious Immunology, Microbiology, Genetic and Blood Test Reagents, Insturments and Test Kits

India in Vitro Diagnostics Industry Report Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Clinical Chemistry, Immunochemistry, Infectious Immunology, Microbiology, Genetic and Blood Test Reagents, Insturments and Test Kits

India In Vitro Diagnostics Industry Report

Summary

This report is an essential source for in-depth information and data relating to India In Vitro Diagnostics market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the In Vitro Diagnostics in India.

Scope

  • The report provides sector information broken down into detailed categories and segments in country.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the industry at a global level, with break downs for the country
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
  • 1 Table Of Contents
    • 1.1 List Of 1.2 List Of 2 Introduction
    • 2.1 What Is This Report About?
    • 2.2 Definitions
      • 2.2.1 In Vitro Diagnostics
      • 2.2.2 Immunochemistry Calibrators and Controls
      • 2.2.3 Immunochemistry Rapid Tests
    • 2.3 Blood Test Reagents
      • 2.3.1 Hematology Test Reagents
      • 2.3.2 Hemostasis Test Reagents
      • 2.3.3 Tissue Typing Reagents
      • 2.3.4 Monoclonal Antibodies
      • 2.3.5 Cytokines and Immunomodulators
      • 2.3.6 Histology and Cytology Reagents
    • 2.4 Microbiology Test Reagents
      • 2.4.1 Bacteriology Test Reagents
      • 2.4.2 Microbiology Calibrators and Controls
      • 2.4.3 Microbiology Rapid Tests
    • 2.5 Infectious Immunology Test Reagents
      • 2.5.1 Bacteriology
      • 2.5.2 Virology
      • 2.5.3 Parasitology
      • 2.5.4 Infectious Immunology Calibrators and Controls
      • 2.5.5 Infectious Immunology Rapid Tests
    • 2.6 Genetic Test Reagents
    • 2.7 Self Testing
    • 2.8 Instruments
  • 3 Healthcare Sector Review
    • 3.1 Healthcare Expenditure
    • 3.2 Healthcare Infrastructure
      • 3.2.1 Healthcare Personnel in India
    • 3.3 Healthcare Policy
  • 4 In Vitro Diagnostics in India
    • 4.1 In Vitro Diagnostics Overall Revenues (2000-2012)
  • 5 Clinical Chemistry Test Reagents in India
    • 5.1 Clinical Chemistry Test Reagents Overall Revenues (2000-2012)
      • 5.1.1 Rapid Tests Overall Revenues (2000-2012)
      • 5.1.2 Laboratory Reagents Overall Revenues (2000-2012)
      • 5.1.3 Calibrators and Controls Overall Revenues (2000-2012)
    • 5.2 Clinical Chemistry Test Reagents Distribution Share (2005-2006)
    • 5.3 Clinical Chemistry Test Reagents Company Share (2005-2006)
  • 6 Self Testing in India
    • 6.1 Self Testing Overall Revenues (2000-2012)
    • 6.2 Self Testing Distribution Share (2005-2006)
    • 6.3 Self Testing Company Share (2005-2006)
  • 7 Immunochemistry Test Reagents in India
    • 7.1 Immunochemistry Test Reagents Overall Revenues (2000-2012)
      • 7.1.1 Disease Specific Test Reagents Overall Revenues (2000-2012)
      • 7.1.2 Disease Specific Markers Overall Revenues (2000-2012)
      • 7.1.3 Hormone Related Testing Reagents Overall Revenues (2000-2012)
      • 7.1.4 Drug Related Testing Reagents Overall Revenues (2000-2012)
      • 7.1.5 Rapid Tests Overall Revenues (2000-2012)
      • 7.1.6 Calibrators and Controls Overall Revenues (2000-2012)
    • 7.2 Immunochemistry Test Reagents Distribution Share (2005-2006)
    • 7.3 Immunochemistry Test Reagents Company Share (2005-2006)
  • 8 Blood Test Reagents in India
    • 8.1 Blood Test Reagents Overall Revenues (2000-2012)
      • 8.1.1 Haematology Test Reagents Overall Revenues (2000-2012)
      • 8.1.2 Hemostasis Test Reagents Overall Revenues (2000-2012)
      • 8.1.3 Monoclonal Antibodies for Cell Surface Ag Overall Revenues (2000-2012)
      • 8.1.4 Histology/ Cytology Reagents Overall Revenues (2000-2012)
      • 8.1.5 Tissue Typing Reagents Overall Revenues (2000-2012)
      • 8.1.6 Cytokines/ Immunomodulators Overall Revenues (2000-2012)
    • 8.2 Blood Test Reagents Distribution Share
    • 8.3 Blood Test Reagents Company Share
  • 9 Infectious Immunology Test Reagents in India
    • 9.1 Infectious Immunology Test Reagents Overall Revenues (2000-2012)
      • 9.1.1 Virology Overall Revenues (2000-2012)
    • 9.2 Infectious Immunology Test Reagents Distribution Share
    • 9.3 Infectious Immunology Test Reagents Company Share
  • 10 Instruments in India
    • 10.1 Instruments Overall Revenues (2000-2012)
    • 10.2 Instruments Distribution Share (2005-2006)
  • 11 Microbiology Test Reagents in India
    • 11.1 Microbiology Test Reagents Overall Revenues (2000-2012)
      • 11.1.1 Bacteriology Test Reagents Overall Revenues (2000-2012)
      • 11.1.2 Rapid Tests Overall Revenues (2000-2012)
      • 11.1.3 Calibrators and Controls Overall Revenues (2000-2012)
    • 11.2 Microbiology Test Reagents Distribution Share
    • 11.3 Microbiology Test Reagents Company Share
  • 12 Genetic Test Reagents in India
    • 12.1 Genetic Test Reagents Overall Revenues (2000-2012)
    • 12.2 Genetic Test Reagents Distribution Share (2005-2006)
    • 12.3 Genetic Test Reagents Company Share (2005-2006)
  • 13 Overview Of Key Companies
    • 13.1 Siemens Medical Solutions Company Overview
    • 13.2 Siemens Medical Solutions Business Overview
      • 13.2.2 Siemens Medical Solutions SWOT Analysis
      • 13.2.3 Siemens Medical Solutions Value Chain Analysis
    • 13.3 F. Hoffmann-La Roche Ltd
      • 13.3.1 F. Hoffmann-La Roche Ltd Company Overview
      • 13.3.2 F. Hoffmann-La Roche Ltd Business Overview
      • 13.3.3 F. Hoffmann-La Roche Ltd Financial Overview
      • 13.3.4 F. Hoffmann-La Roche Ltd SWOT Analysis
      • 13.3.5 F. Hoffmann-La Roche Ltd Value Chain Analysis
    • 13.4 Abbott Laboratories
      • 13.4.1 Abbott Laboratories Company Overview
      • 13.4.2 Abbott Laboratories Business Overview
      • 13.4.3 Abbot laboratories Financial Overview
      • 13.4.4 Abbott laboratories SWOT Analysis
      • 13.4.5 Abbott Laboratories Value Chain Analysis
    • 13.5 Becton, Dickinson and Company
      • 13.5.1 Becton, Dickinson and Company's Company Overview
      • 13.5.2 Becton, Dickinson and Company's Business Overview
      • 13.5.3 Becton, Dickinson and Company's Financial Overview
      • 13.5.4 Becton, Dickinson and Company's SWOT Analysis
      • 13.5.5 Becton, Dickinson and Company's Value Chain Analysis
  • 14 Regulation System
    • 14.1 Medical Equipment Approval
    • 14.2 Central Drugs Authority of India (CDAI)
    • 14.3 Medical Device Regulatory Authority of India (MDRAI)
    • 14.4 Classification of Medical Devices
      • 14.4.1 Registration Period
  • 15 Pricing and Reimbursement
    • 15.1 Pricing and Reimbursement
  • 16 Distribution Structure
    • 16.1 Distribution Structure
  • 17 APPENDIX
    • 17.1 Methodology
    • 17.2 Currency Conversion
    • 17.3 Contact Us
    • 17.4 Disclaimer
    • 1.1 List Of Table 1: Healthcare Personnel by Specialty in India, 2000-2007
  • List of Tables
    • Table 2: In Vitro Diagnostics, India, Overall Revenues ($ mn), 2000-2012
    • Table 3: In Vitro Diagnostics, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 4: In Vitro Diagnostics, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 5: In Vitro Diagnostics, India, Category Revenues ($ mn), 2000-2012
    • Table 6: In Vitro Diagnostics, India, Category Revenues ($ mn), Historic, 2000-2007
    • Table 7: In Vitro Diagnostics, India, Category Revenues ($ mn), Forecast, 2007-2012
    • Table 8: Clinical Chemistry Test Reagents, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 9: Clinical Chemistry Test Reagents, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 10: Clinical Chemistry Test Reagents, India, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 11: Clinical Chemistry Test Reagents, India, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 12: Rapid Tests, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 13: Rapid Tests, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 14: Laboratory Reagents, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 15: Laboratory Reagents, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 16: Calibrators and Controls, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 17: Calibrators and Controls, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 18: Clinical Chemistry Test Reagents, India, Distribution Share by Revenue , 2005-2006
    • Table 19: Clinical Chemistry Test Reagents, India, Company Share by Revenue , 2005-2006
    • Table 20: Self Testing, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 21: Self Testing, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 22: Self Testing, India, Distribution Share by Revenue , 2005-2006
    • Table 23: Self Testing, India, Company Share by Revenue , 2005-2006
    • Table 24: Immunochemistry Test Reagents, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 25: Immunochemistry Test Reagents, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 26: Immunochemistry Test Reagents, India, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 27: Immunochemistry Test Reagents, India, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 28: Disease Specific Test Reagents , India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 29: Disease Specific Test Reagents , India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 30: Disease Specific Test Reagents , India, Overall Revenues by Sub segment ($ mn), Historic, 2000-2007
    • Table 31: Disease Specific Test Reagents , India, Overall Revenues by Sub Segment($ mn), Forecast, 2007-2012
    • Table 32: Allergy, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 33: Allergy, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 34: Anaemia/ Vitamins, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 35: Anaemia/ Vitamins, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 36: Rheumatoid Disease, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 37: Rheumatoid Disease, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 38: Auto-Immune Disease, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 39: Auto-Immune Disease, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 40: Disease Specific Markers, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 41: Disease Specific Markers, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 42: Disease Specific Markers, India, Overall Revenues by Sub-Segment ($ mn), Historic, 2000-2007
    • Table 43: Disease Specific Markers, India, Overall Revenues by Sub-Segment ($ mn), Forecast, 2007-2012
    • Table 44: Tumour Markers, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 45: Tumour Markers, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 46: Cardiac Markers, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 47: Cardiac Markers, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 48: Hormone Related Testing Reagents, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 49: Hormone Related Testing Reagents, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 50: Hormone Related Testing Reagents, India, Overall Revenues by Sub Segment($ mn), Historic, 2000-2007
    • Table 51: Hormone Related Testing Reagents, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 52: Specific Proteins, India, Overall Revenue ($ mn), Historic, 2000-2007
    • Table 53: Specific Proteins, India, Overall Revenue ($ mn), Historic, 2000-2007
    • Table 54: Fertility/ Pregnancy, India, Overall Revenue ($ mn), Historic, 2000-2007
    • Table 55: Fertility/ Pregnancy, India, Overall Revenue ($ mn), Forecast, 2007-2012
    • Table 56: Individual/ Specified hormones, India, Overall Revenue ($ mn), Historic, 2000-2007
    • Table 57: Individual/ Specified hormones, India, Overall Revenue ($ mn), Historic, 2007-2012
    • Table 58: Specific Organ Function, India, Overall Revenue ($ mn), Historic, 2000-2007
    • Table 59: Specific Organ Function, India, Overall Revenue ($ mn), Forecast, 2007-2012
    • Table 60: Drug Related Testing Reagents, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 61: Drug Related Testing Reagents, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 62: Drug Related Testing Reagents, India, Overall Revenues by Sub-Segment ($ mn), Historic, 2000-2007
    • Table 63: Drug Related Testing Reagents, India, Overall Revenues by Sub-Segment ($ mn), Forecast, 2007-2012
    • Table 64: Therapeutic Drugs, India, Overall Revenue ($ mn), Historic, 2000-2007
    • Table 65: Therapeutic Drugs, India, Overall Revenue ($ mn), Forecast, 2007-2012
    • Table 66: Drug of Abuse and Toxicology, India, Overall Revenue ($ mn), Historic, 2000-2007
    • Table 67: Drug of Abuse and Toxicology, India, Overall Revenue ($ mn), Forecast, 2007-2012
    • Table 68: Rapid Tests, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 69: Rapid Tests, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 70: Calibrators and Controls, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 71: Calibrators and Controls, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 72: Immunochemistry Test Reagents, India, Distribution Share by Revenue , 2005-2006
    • Table 73: Immunochemistry Test Reagents, India, Company Share by Revenue , 2005-2006
    • Table 74: Blood Test Reagents, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 75: Blood Test Reagents, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 76: Blood Test Reagents, India, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 77: Blood Test Reagents, India, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 78: Haematology Test Reagents, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 79: Haematology Test Reagents, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 80: Haematology Test Reagents, India, Overall Revenues by Sub-Segment ($ mn), Historic, 2000-2007
    • Table 81: Haematology Test Reagents, India, Overall Revenues by Sub-Segment ($ mn), Forecast, 2007-2012
    • Table 82: Haematology, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 83: Haematology, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 84: Immunohaematology, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 85: Immunohaematology, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 86: Haematology Calibrators and Controls, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 87: Haematology Calibrators and Controls, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 88: Immunohaematology Controls, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 89: Immunohaematology Controls, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 90: Hemostasis Test Reagents, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 91: Hemostasis Test Reagents, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 92: Hemostasis Test Reagents, India, Overall Revenues by Sub-Segment ($ mn), Historic, 2000-2007
    • Table 93: Hemostasis Test Reagents, India, Overall Revenues by Sub-Segment ($ mn), Forecast, 2007-2012
    • Table 94: Hemostasis, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 95: Hemostasis, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 96: Calibrators and Controls, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 97: Calibrators and Controls, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 98: Rapid Tests, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 99: Rapid Tests, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 100: Monoclonal Antibodies for Cell Surface Ag, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 101: Monoclonal Antibodies for Cell Surface Ag, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 102: Histology/ Cytology Reagents, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 103: Histology/ Cytology Reagents, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 104: Tissue Typing Reagents, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 105: Tissue Typing Reagents, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 106: Cytokines/ Immunomodulators, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 107: Cytokines/ Immunomodulators, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 108: Blood Test Reagents, India, Distribution Share by Revenue , 2005-2006
    • Table 109: Blood Test Reagents, India, Company Share by Revenue , 2005-2006
    • Table 110: Infectious Immunology Test Reagents, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 111: Infectious Immunology Test Reagents, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 112: Infectious Immunology Test Reagents, India, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 113: Infectious Immunology Test Reagents, India, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 114: Virology, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 115: Virology, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 116: Virology, India, Overall Revenues by Sub-Segment ($ mn), Historic, 2000-2007
    • Table 117: Virology, India, Overall Revenues by Sub-Segment ($ mn), Forecast, 2007-2012
    • Table 118: Hepatitis Viruses, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 119: Hepatitis Viruses, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 120: Retroviruses, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 121: Retroviruses, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 122: Bacteriology, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 123: Bacteriology, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 124: Parasitology, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 125: Parasitology, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 126: Rapid Tests, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 127: Rapid Tests, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 128: Calibrators and Controls, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 129: Calibrators and Controls, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 130: Infectious Immunology Test Reagents, India, Distribution Share by Revenue , 2005-2006
    • Table 131: Infectious Immunology Test Reagents, India, Company Share by Revenue , 2005-2006
    • Table 132: Instruments, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 133: Instruments, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 134: Instruments, India, Distribution Share by Revenue , 2005-2006
    • Table 135: Microbiology Test Reagents, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 136: Microbiology Test Reagents, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 137: Microbiology Test Reagents, India, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 138: Microbiology Test Reagents, India, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 139: Bacteriology Test Reagents, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 140: Bacteriology Test Reagents, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 141: Bacteriology Test Reagents, India, Overall Revenues by Sub-Segment ($ mn), Historic, 2000-2007
    • Table 142: Bacteriology Test Reagents, India, Overall Revenues by Sub-Segment ($ mn), Forecast, 2007-2012
    • Table 143: Bacteriology Culture, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 144: Bacteriology Culture, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 145: Identification and Susceptibility, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 146: Identification and Susceptibility, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 147: Blood Culture, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 148: Blood Culture, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 149: Rapid Tests, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 150: Rapid Tests, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 151: Calibrators and Controls, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 152: Calibrators and Controls, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 153: Microbiology Test Reagents, India, Distribution Share by Revenue , 2005-2006
    • Table 154: Microbiology Test Reagents, India, Company Share by Revenue , 2005-2006
    • Table 155: Genetic Test Reagents, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 156: Genetic Test Reagents, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 157: Genetic Test Reagents, India, Distribution Share by Revenue , 2005-2006
    • Table 158: Genetic Test Reagents, India, Company Share by Revenue , 2005-2006
    • Table 159: F. Hoffmann-La Roche Ltd. Financial and Operational Overview, 2006-2002
    • Table 160: F. Hoffmann-La Roche Ltd. Financial and Operational Overview, 2006-2002
    • Table 161: Abbott Laboratories Financial and Operational Overview, 2006-2002
    • Table 162: Abbott Laboratories Financial and Operational Overview, 2006-2002
    • Table 163: Becton, Dickinson and Company Financial and Operational Overview, 2006-2002
    • Table 164: Becton, Dickinson and Company Financial and Operational Overview, 2006-2002
    • Table 165: Currency Conversion to USD at 2006 Constant Rate
+44 20 8816 8548

Ask a question about India in Vitro Diagnostics Industry Report

Enter the characters you see in the picture below
Captcha